{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:07:02Z","timestamp":1790518022109,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009657","name":"FSHD Global Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.nmd.2021.09.010","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T08:41:54Z","timestamp":1633336914000},"page":"1101-1112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-8074","authenticated-orcid":false,"given":"Fangzhi Frank","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth Alexander","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-6962","authenticated-orcid":false,"given":"Kishore Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.09.010_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20522","article-title":"Facioscapulohumeral muscular dystrophy","volume":"34","author":"Tawil","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.09.010_bib0002","doi-asserted-by":"crossref","unstructured":"S. Pandya, W.M. King, R. Tawil Facioscapulohumeral dystrophy. Physical Therapy, 2008;88:105\u2013113, doi: 10.2522\/ptj.20070104.","DOI":"10.2522\/ptj.20070104"},{"key":"10.1016\/j.nmd.2021.09.010_bib0003","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-0004.2009.01158.x","article-title":"Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample","volume":"75","author":"Mostacciuolo","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0004","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-016-0667-0","article-title":"Facioscapulohumeral dystrophy","volume":"16","author":"Wang","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.nmd.2021.09.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2010.04.007","article-title":"171st ENMC International Workshop: Standards of care and management of facioscapulohumeral muscular dystrophy","volume":"20","author":"Tawil","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awt226","article-title":"Large scale genotype\u2013phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy","volume":"136","author":"Ricci","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.09.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2012.02.019","article-title":"Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy","volume":"90","author":"Scionti","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78578-7","article-title":"Large genotype\u2013phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis","volume":"10","author":"Ricci","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2021.09.010_bib0010","unstructured":"G. Padberg Facioscapulohumeral disease. [PhD thesis]. Leiden, The Netherlands: University of Leiden; 1982."},{"key":"10.1016\/j.nmd.2021.09.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/110.3.631","article-title":"Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy","volume":"110","author":"Fitzsimons","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.09.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e3182897116","article-title":"Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size","volume":"80","author":"Statland","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.41.12.1878","article-title":"Hearing loss in facioscapulohumeral muscular dystrophy","volume":"41","author":"Brouwer","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0014","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nmd.2021.09.010_bib0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2011.01.001","article-title":"Facioscapulohumeral muscular dystrophy and DUX4: Breaking the silence","volume":"17","author":"van der Maarel","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nmd.2021.09.010_bib0016","article-title":"A large patient study confirming that facioscapulohumeral muscular dystrophy (FSHD) disease expression is almost exclusively associated with an FSHD locus located on a 4qA-defined 4qter subtelomere","volume":"44","author":"Thomas","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011412","article-title":"CLIA laboratory testing for facioscapulohumeral dystrophy (FSHD): a retrospective analysis","volume":"96","author":"Rieken","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/jmedgenet-2011-100454","article-title":"Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling","volume":"49","author":"Scionti","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0019","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/hmg\/ddu486","article-title":"Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2","volume":"24","author":"Lemmers","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0020","article-title":"Epigenetic mechanisms of facioscapulohumeral muscular dystrophy. Mutation research\/fundamental and molecular mechanisms of","volume":"647","author":"de Greef","year":"2008","journal-title":"Mutagenesis"},{"key":"10.1016\/j.nmd.2021.09.010_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/BF01553323","article-title":"The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease","volume":"2","author":"Winokur","year":"1994","journal-title":"Chromosome Res"},{"key":"10.1016\/j.nmd.2021.09.010_bib0022","article-title":"The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region","volume":"5","author":"Winokur","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/519311","article-title":"Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy","volume":"81","author":"Clapp","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0024","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2148-10-364","article-title":"A family history of DUX4: Phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene","volume":"10","author":"Leidenroth","year":"2010","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00412-012-0380-y","article-title":"Evolution of DUX gene macrosatellites in placental mammals","volume":"121","author":"Leidenroth","year":"2012","journal-title":"Chromosoma"},{"key":"10.1016\/j.nmd.2021.09.010_bib0026","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/ng1262","article-title":"Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy","volume":"35","author":"van Overveld","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3858","article-title":"DUX-family transcription factors regulate zygotic genome activation in placental mammals","volume":"49","author":"de Iaco","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3844","article-title":"Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL\/HERVL retrotransposons","volume":"49","author":"Hendrickson","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3846","article-title":"Conservation and innovation in the DUX4-family gene network","volume":"49","author":"Whiddon","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/ana.22275","article-title":"DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo","volume":"69","author":"Wallace","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026820","article-title":"The FSHD atrophic myotube phenotype is caused by DUX4 expression","volume":"6","author":"Vanderplanck","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2021.09.010_bib0033","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-8-8","article-title":"The facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure","volume":"8","author":"Rossi","year":"2007","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0034","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/humu.21091","article-title":"Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD","volume":"30","author":"de Greef","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.09.010_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2010.01.035","article-title":"Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution","volume":"86","author":"Lemmers","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0036","unstructured":"J.R. Gilbert, J.M. Stajich, S. Wall, S.C. Carter, H. Qiu, J.M. Vance, et al. Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet. 1993;53(2):401\u2013408."},{"key":"10.1016\/j.nmd.2021.09.010_bib0037","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0038","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/humu.22792","article-title":"Hemizygosity for SMCHD1 in facioscapulohumeral muscular dystrophy type 2: consequences for 18p deletion syndrome","volume":"36","author":"Lemmers","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.09.010_bib0039","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0040","article-title":"Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations","volume":"26","author":"Hamanaka","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0041","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1093\/hmg\/ddy236","article-title":"Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2","volume":"27","author":"Lemmers","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0042","doi-asserted-by":"crossref","first-page":"E2273","DOI":"10.1212\/WNL.0000000000007456","article-title":"FSHD1 and FSHD2 form a disease continuum","volume":"92","author":"Sacconi","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/jmedgenet-2019-106168","article-title":"SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain","volume":"56","author":"Lemmers","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000559","article-title":"Specific loss of histone H3 lysine 9 trimethylation and HP1\u03b3\/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD)","volume":"5","author":"Zeng","year":"2009","journal-title":"PLos Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/ng.142","article-title":"SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation","volume":"40","author":"Blewitt","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2012.06.011","article-title":"Smchd1-dependent and -independent pathways determine developmental dynamics of CpG island methylation on the inactive X chromosome","volume":"23","author":"Gendrel","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.nmd.2021.09.010_bib0047","article-title":"Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation","volume":"6","author":"Mould","year":"2013","journal-title":"Epig Chromatin"},{"key":"10.1016\/j.nmd.2021.09.010_bib0048","article-title":"Genome-wide binding and mechanistic analyses of smchd1-mediated epigenetic regulation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nmd.2021.09.010_bib0049","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddx437","article-title":"Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model","volume":"27","author":"de Greef","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2015.1113798","article-title":"Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4","volume":"10","author":"Balog","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.nmd.2021.09.010_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-9525(02)02709-9","article-title":"Metastable epialleles in mammals","volume":"18","author":"Rakyan","year":"2002","journal-title":"Trends Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2013.08.009","article-title":"Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2","volume":"23","author":"Mitsuhashi","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2014.58","article-title":"Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy","volume":"23","author":"Winston","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0054","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ejhg.2014.191","article-title":"Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1","volume":"23","author":"Larsen","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2015.55","article-title":"Double SMCHD1 variants in FSHD2: the synergistic effect of two SMCHD1 variants on D4Z4 hypomethylation and disease penetrance in FSHD2","volume":"24","author":"van den Boogaard","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0056","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/hmg\/ddz239","article-title":"The variability of SMCHD1 gene in FSHD patients: evidence of new mutations","volume":"28","author":"Strafella","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0057","doi-asserted-by":"crossref","DOI":"10.1136\/jmedgenet-2019-106402","article-title":"Intronic SMCHD1 variants in FSHD: testing the potential for CRISPR-Cas9 genome editing","volume":"56","author":"Goossens","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0058","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jmedgenet-2017-105153","article-title":"Monosomy 18p is a risk factor for facioscapulohumeral dystrophy","volume":"55","author":"Balog","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0059","doi-asserted-by":"crossref","unstructured":"D. Renard, G. Taieb, M. Garibaldi, P.M. Andre de , R. Bernard, et al. Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome 2018. 10.1002\/ajmga.38843.","DOI":"10.1002\/ajmg.a.38843"},{"key":"10.1016\/j.nmd.2021.09.010_bib0060","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2013.08.004","article-title":"The FSHD2 gene SMCHD1 Is a modifier of disease severity in families affected by FSHD1","volume":"93","author":"Sacconi","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0061","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3765","article-title":"De novo mutations in SMCHD1 cause bosma arhinia microphthalmia syndrome and abrogate nasal development","volume":"49","author":"Gordon","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0062","article-title":"SMCHD1 mutations associated with a rare muscular dystrophy can also cause isolated arhinia and Bosma arhinia microphthalmia syndrome","volume":"49","author":"Shaw","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0063","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005958","article-title":"FSHD type 2 and Bosma arhinia microphthalmia syndrome","volume":"91","author":"Mul","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0064","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.003104","article-title":"FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function","volume":"293","author":"Gurzau","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.09.010_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00140","article-title":"DNMT3B functions: novel insights from human disease","volume":"6","author":"Gagliardi","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115278","article-title":"DNA methylation analysis of the macrosatellite repeat associated with FSHD muscular dystrophy at single nucleotide level","volume":"9","author":"Huichalaf","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2021.09.010_bib0067","article-title":"Dnmt3b regulates DUX4 expression in a tissue-dependent manner in transgenic D4Z4 mice","volume":"10","author":"Bouwman","year":"2020","journal-title":"Skel. Muscle"},{"key":"10.1016\/j.nmd.2021.09.010_bib0068","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.96.25.14412","article-title":"The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome","volume":"96","author":"Hansen","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nmd.2021.09.010_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/humu.20113","article-title":"DNMT3B mutations and DNA methylation defect define two types of ICF syndrome","volume":"25","author":"Jiang","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.09.010_bib0070","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/9.4.597","article-title":"Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2","volume":"9","author":"Kondo","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0071","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm341","article-title":"DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function","volume":"17","author":"Jin","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0072","doi-asserted-by":"crossref","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","article-title":"Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy","volume":"94","author":"Hamanaka","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0073","doi-asserted-by":"crossref","DOI":"10.1038\/nsmb.2532","article-title":"Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway","volume":"20","author":"Nozawa","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0074","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/humu.23304","article-title":"Molecular combing reveals complex 4q35 rearrangements in facioscapulohumeral dystrophy","volume":"38","author":"Nguyen","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.09.010_bib0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41431-017-0015-0","article-title":"Deep characterization of a common D4Z4 variant identifies biallelic DUX4 expression as a modifier for disease penetrance in FSHD2","volume":"26","author":"Lemmers","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0076","article-title":"Cellular and animal models for facioscapulohumeral muscular dystrophy","volume":"13","author":"DeSimone","year":"2020","journal-title":"DMM Dis. Models Mech."},{"key":"10.1016\/j.nmd.2021.09.010_bib0077","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2011.213","article-title":"A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function","volume":"20","author":"Homma","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0078","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/dds284","article-title":"Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis","volume":"21","author":"Jones","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0079","article-title":"Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population","volume":"1","author":"Stadler","year":"2011","journal-title":"Skel. Muscle"},{"key":"10.1016\/j.nmd.2021.09.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2012.07.007","article-title":"Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient","volume":"181","author":"Krom","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2016.12.007","article-title":"Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy","volume":"27","author":"Jones","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0082","doi-asserted-by":"crossref","DOI":"10.5966\/sctm.2015-0224","article-title":"A human pluripotent stem cell model of facioscapulohumeral muscular dystrophy-affected skeletal muscles","volume":"5","author":"Caron","year":"2016","journal-title":"STEM CELLS Transl. Med."},{"key":"10.1016\/j.nmd.2021.09.010_bib0083","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy293","article-title":"A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4","volume":"27","author":"Sasaki-Honda","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.101884","article-title":"Generation of a transgene-free iPSC line and genetically modified line from a facioscapulohumeral muscular dystrophy type 2 (FSHD2) patient with SMCHD1 p.Lys607Ter mutation","volume":"47","author":"Sasaki-Honda","year":"2020","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.nmd.2021.09.010_bib0085","article-title":"DUX4 signalling in the pathogenesis of facioscapulohumeral muscular dystrophy","volume":"21","author":"Lim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2021.09.010_bib0086","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy162","article-title":"Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle","volume":"27","author":"Campbell","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0087","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.119.259663","article-title":"Clinically advanced p38 inhibitors suppress DUX4 expression in cellular and animal models of facioscapulohumeral muscular dystrophy","volume":"370","author":"Oliva","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nmd.2021.09.010_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113011","article-title":"Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy","volume":"320","author":"Mueller","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0089","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1124\/jpet.119.264689","article-title":"p38a regulates expression of DUX4 in a model of facioscapulohumeral muscular dystrophys","volume":"374","author":"Rojas","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nmd.2021.09.010_bib0090","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000000849","article-title":"The prospects of targeting DUX4 in facioscapulohumeral muscular dystrophy","volume":"33","author":"Bouwman","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0091","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/jcm9092886","article-title":"Therapeutic Strategies Targeting DUX4 in FSHD","volume":"9","author":"le Gall","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nmd.2021.09.010_bib0092","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.180372","article-title":"DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis","volume":"129","author":"Knopp","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.nmd.2021.09.010_bib0093","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy400","article-title":"Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development","volume":"28","author":"van den Heuvel","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0094","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008754","article-title":"Single-nucleus RNA-seq identifies divergent populations of FSHD2 myotube nuclei","volume":"16","author":"Jiang","year":"2020","journal-title":"PLos Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0095","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0096","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/ene.14446","article-title":"Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging","volume":"27","author":"Giacomucci","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0097","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000000708","article-title":"Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers","volume":"83","author":"Gaillard","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0098","doi-asserted-by":"crossref","unstructured":"J.C. de Greef, R. Lemmers, P. Cama\u00f1o, J.W. Day, S. Sacconi, M. Dunand, et al. Clinical features of facioscapulohumeral muscular dystrophy 2. 2010.","DOI":"10.1212\/WNL.0b013e3181f96175"},{"key":"10.1016\/j.nmd.2021.09.010_bib0099","doi-asserted-by":"crossref","DOI":"10.1002\/mus.21308","article-title":"Quality of life and pain in patients with facioscapulohumeral muscular dystrophy","volume":"40","author":"Padua","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.09.010_bib0100","doi-asserted-by":"crossref","DOI":"10.1159\/000452763","article-title":"Leg muscle involvement in facioscapulohumeral muscular dystrophy: comparison between facioscapulohumeral muscular dystrophy types 1 and 2","volume":"77","author":"Mair","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0101","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004647","article-title":"Adding quantitative muscle MRI to the FSHD clinical trial toolbox","volume":"89","author":"Mul","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0102","doi-asserted-by":"crossref","DOI":"10.1212\/CON.0000000000000399","article-title":"Facioscapulohumeral muscular dystrophy","volume":"22","author":"Statland","year":"2016","journal-title":"CONTINUUM: Lifelong Learn. Neurol."},{"key":"10.1016\/j.nmd.2021.09.010_bib0103","series-title":"GeneReviews","article-title":"Facioscapulohumeral muscular dystrophy","author":"Preston","year":"2020"},{"key":"10.1016\/j.nmd.2021.09.010_bib0104","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.1995.00540350055017","article-title":"Scapuloperoneal syndromes: absence of linkage to the 4q35 FSHD locus","volume":"52","author":"Tawil","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0105","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awh052","article-title":"Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients","volume":"127","author":"Selcen","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.09.010_bib0106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jmedgenet-2011-100101","article-title":"Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity","volume":"49","author":"Sacconi","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0107","doi-asserted-by":"crossref","DOI":"10.1179\/174313209X380847","article-title":"The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)","volume":"32","author":"Angelini","year":"2010","journal-title":"Neurol Res"},{"key":"10.1016\/j.nmd.2021.09.010_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2010.03.002","article-title":"Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings","volume":"20","author":"Kumar","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0109","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2015-310362","article-title":"Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK","volume":"87","author":"Figueroa-Bonaparte","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.09.010_bib0110","doi-asserted-by":"crossref","DOI":"10.1002\/humu.22760","article-title":"Identification of variants in the 4q35 Gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype","volume":"36","author":"Puppo","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.09.010_bib0111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003550","article-title":"Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy","volume":"9","author":"Caruso","year":"2013","journal-title":"PLos Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0112","doi-asserted-by":"crossref","DOI":"10.3349\/ymj.2018.59.2.337","article-title":"FAT1 gene alteration in facioscapulohumeral muscular dystrophy Type 1","volume":"59","author":"Park","year":"2018","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.nmd.2021.09.010_bib0113","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000001783","article-title":"Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0114","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e31827f075c","article-title":"A focal domain of extreme demethylation within D4Z4 in FSHD2","volume":"80","author":"Hartweck","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.09.010_bib0115","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-6-23","article-title":"Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing","volume":"6","author":"Jones","year":"2014","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.nmd.2021.09.010_bib0116","doi-asserted-by":"crossref","DOI":"10.1136\/jmedgenet-2015-103436","article-title":"Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2","volume":"53","author":"Calandra","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.09.010_bib0117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13712-6","article-title":"Nanopore-based single molecule sequencing of the D4Z4 array responsible for facioscapulohumeral muscular dystrophy","volume":"7","author":"Mitsuhashi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2021.09.010_bib0118","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-021-01201-x","article-title":"An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics","volume":"9","author":"Chintalaphani","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nmd.2021.09.010_bib0119","doi-asserted-by":"crossref","DOI":"10.1101\/gr.240739.118","article-title":"Long-read single-molecule maps of the functional methylome","volume":"29","author":"Sharim","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.nmd.2021.09.010_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24640","article-title":"Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trials","volume":"79","author":"Tasca","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0121","article-title":"Magnetic resonance imaging in facioscapulohumeral muscular dystrophy","volume":"57","author":"Leung","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.09.010_bib0122","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-016-8361-3","article-title":"MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients","volume":"264","author":"Andersen","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.09.010_bib0123","article-title":"Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Musculoskeletal Disord."},{"key":"10.1016\/j.nmd.2021.09.010_bib0124","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-236444","article-title":"Use of muscle MRI in an atypical presentation of FSHD2","volume":"13","author":"Jesuthasan","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.nmd.2021.09.010_bib0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.nmd.2014.06.012","article-title":"G.O.4","volume":"24","author":"van den Boogaard","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.09.010_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocn.2018.10.021","article-title":"Different clinicopathological features between Japanese siblings with facioscapulohumeral muscular dystrophy 2 with a novel nonsense SMCHD1 mutation (Arg552\u2217)","volume":"58","author":"Ohta","year":"2018","journal-title":"J Clin Neurosci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621006568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621006568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:27Z","timestamp":1760775087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621006568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":126,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0960896621006568"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.09.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facioscapulohumeral muscular dystrophy type 2: an update on the clinical, genetic, and molecular findings","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}